Newsbenzinga
Regenxbio Gains Fresh Chance As FDA Reconsiders Gene Therapy
· Published
Article summary
FDA reverses its rejection of Regenxbio Navsunli, allowing the company to refile its gene therapy application.
An excerpt from the original article.
Comments —
Loading comments…